Prashanth Vishwanathan/BloombergThe bacteria-laced drinks are pitched to aid intestinal flora
Meenakshi,
one of hundreds of young women who zip around India’s dusty streets on
scooters promoting the dairy drink Yakult, says health is her best sales
pitch. The 22-year-old student knocks on doors two days a week to tell
stay-at-home mothers, washing ladies, and residents living in makeshift
shacks how Yakult’s microbes can help cultivate their “intestinal
flora.” She gives a short rehearsed speech—the product’s 6.5 billion
friendly bacteria per bottle help build immunity and protect against
constipation, diarrhea, and infections—before passing out corporate
leaflets to back up her assertions. “Customers do say their digestive
systems have improved,” says Meenakshi, who uses one name only. “Regular
customers rarely get infections.”
That’s a pitch fermented drink
makers such as Japan’s Yakult Honsha and Danone, the maker of Dannon,
can’t use in much of the West, where regulators have been tough on food
health claims. Danone in 2010 withdrew marketing claims in Europe that
its Actimel fermented drink could boost the immune system because it
contains probiotics—bacteria that encourage other helpful microbes to
flourish in the bowel. The same year, the European Food Safety Authority
rejected the Paris-based company’s claim that Actimel reduced one’s
chances of developing diarrhea. It also ruled that Yakult couldn’t say
its drink wards off respiratory tract infections.
In the U.S., Danone in
2010 was prohibited from advertising that its Activia yogurt and
DanActive dairy drink could help consumers avoid catching colds or flu
and had restrictions placed on claims regarding irregularity. Dannon,
which agreed to pay $21 million as part of a settlement with the Federal
Trade Commission and 39 states, did not admit any wrongdoing.
Photograph by Prashanth Vishwanathan/BloombergSome of the 250 Yakult Ladies gather before hitting the road

Companies
have more leeway to make such claims in Asia. So the dairy aisles of
Chinese and Indian supermarkets are a riot of brightly colored packages
of fermented milk drinks promising health benefits. Alongside Yakult and
Danone’s Activa products are local offerings such as Shuang WaiWai and
Amul’s ProLife. “Asia is increasingly becoming the place to be for
probiotics producers,” says Martin Jochum of SAM Sustainable Assets
Management in Zurich. “The regulatory environment there is a lot more
favorable than in Europe, and you have a lot of consumers that are
demanding better-quality nutrition.”
Yakult, a household name in
Japan for more than 50 years, has climbed to No. 3 among probiotic dairy
beverages in China, with sales of $174 million in 2010, according to
researcher Euromonitor International. The company says it hasn’t
targeted any particular country due to its ability to make health claims
there. Still, Yakult says that in much of China, regulators allow it to
claim the drink helps with “immuno-regulation and improving intestinal
flora.” In Taiwan, it can say the beverage increases beneficial
bacteria.
Photograph by Prashanth Vishwanathan/BloombergMeenakshi giving probiotic drinks to customers

In
India, which Yakult entered in 2008 and where it has a joint venture
with Danone, the company has hired Bollywood star Kajol Devgan as a
brand ambassador. It employs 250 “Yakult Ladies” who zoom around cities
on scooters to tell buyers how the drinks can improve their health.
Companies can make general claims about probiotics improving digestion
or bolstering immunity as long as they don’t suggest products can heal
specific diseases.
Although its Indian revenues are small—about
$2 million in 2010, according to Euromonitor—Yakult has increased its
sales there by at least 60 percent every year. The global market for
foods containing probiotics will probably grow 51 percent, to
$42 billion, by 2016, figures Euromonitor. For fortified drinks such as
Actimel and Yakult, the Asia-Pacific region is the No. 2 market after
North America, generating about $18 billion in sales last year,
Euromonitor says. Western Europe ranks third at $11 billion.
Photograph by Prashanth Vishwanathan/Bloomberg

Danone,
which already owns 20 percent of Yakult, has for months been
negotiating to raise its stake, say Japanese press reports. Both
companies declined to comment on talks. An existing accord between the
two allows Danone to increase its holding this year, though it’s
prevented from taking “effective majority control” of Yakult until 2017.
The two companies also have a joint venture in Vietnam. “The more we
work with Yakult, the more we appreciate working with them,” Danone
Chief Financial Officer Pierre-André Terisse told investors in April.
“We need to keep developing and increasing these cooperations.”
The bottom line: Global sales of probiotic-enhanced products, growing in popularity across Asia, could rise 51 percent, to $42 billion, by 2016.
Tidak ada komentar:
Posting Komentar